Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy — Stella

Home/Breast Cancer Female/Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer Female trials

Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy

Trial locations(1 site)

France

Institut Paoli-Calmettes, Marseille, Marseille

Key details

Sponsor

Institut Paoli-Calmettes

Enrollment target

~150 participants

Started

November 2022

Primary completion

December 2027

Age range

18 Years and older

Sex

Female only

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.